Page 1203 - Basic _ Clinical Pharmacology ( PDFDrive )

Index 1189

Anticholinergic agents, 124. See also specific SSRIs, 548, 548t d-phenylalanine derivatives, 759,
agents tetracyclic and unicyclic, 768t
antiemetic properties of, 1106 548t, 549 meglitinide analogs, 759, 768t
irritable bowel syndrome treated with, overdose in, 547–548 sulfonylureas, 757–759, 758t, 768t
1101–1102 selection of, 545 Antidiarrheal agents
poisoning management for, 1041t, 1042 drug interactions of bile salt–binding resins, 1100
Anticoagulants, 611–618, 624t. See also heterocyclic antidepressants, 1159t colloidal bismuth compounds, 1100
specific drugs tricyclic antidepressants, 1159t octreotide, 1101
direct factor Xa inhibitors, oral, 616–617 in elderly, 542t, 1061–1062 opioid agonists, 1100
direct thrombin inhibitors indications for, 532 opioids for, 563
oral, 618 on NET, 95 OTC, 1123t–1124t
parenteral, 617–618 non-depression uses of, 533 use of, 1101, 1115t
indirect thrombin inhibitors, heparin, pathophysiology of depression and, 533f, Antidiuretic hormone (ADH), 268.
612f, 612–616 533–536, 535f See Vasopressin
oral, drug interactions of, 1158t–1159t pharmacodynamics of, 541–543 Antidotes, 1040, 1041t
pharmacology of, basic, 614–617 5-HT receptor modulators, 542t, 543 Antiemetic agents, 1103–1106, 1116t
warfarin and other coumarins, 614–616 MAO inhibitors, 542t, 543 benzodiazepines, 1106
Anticonvulsants, 389. See also Antiseizure SNRIs, 542, 542t cannabinoids, 1106, 1116t
drugs SSRIs, 541–542, 542t corticosteroids, 1105
Antidepressant agents, 532–552, 549t–550t. tetracyclic and unicyclic agents, 542t, H 1 antihistamines and anticholinergic
See also specific agents 543 drugs, 1106
chemistry and subgroups of, 536–539 tricyclic antidepressants, 542t, mechanisms of action of, 1103, 1104f
5-HT 2 receptor modulators, 538 542–543 neurokinin receptor antagonists, 1105
monoamine oxidase inhibitors, 539 pharmacokinetics of phenothiazines and butyrophenones,
selective serotonin reuptake inhibitors, 5-HT receptor modulators, 1105–1106
536, 537f 540t, 541 serotonin 5-HT3-antagonists,
serotonin-norepinephrine reuptake MAO inhibitors, 540t, 541 1103–1105, 1116t, 1117t
inhibitors SNRIs, 540, 540t substituted benzamides, 1106
selective serotonin-norepinephrine SSRIs, 539–540, 540t Antiepileptics, 409–439. See also
reuptake inhibitors, 536–537 tetracyclic and unicyclic agents, 540t, Antiseizure drugs
tricyclic antidepressants, 537, 538f 541 Antifolate drugs, 834–837. See also specific
tetracyclics, 538–539, 539f tricyclic antidepressants, 540t, 541 drugs
unicyclic, 538–539, 539f poisoning with, 1041t, 1042 DNA gyrase inhibitors, 837–840, 840t
clinical pharmacology of, 543–549 preparations available, 551t methotrexate, 957, 958t
adverse effects of prevalence of use of, 532 pemetrexed, 957–958, 958t
5-HT receptor modulators, 547 tricyclic. See Tricyclic antidepressants pralatrexate, 958–959
MAO inhibitors, 547 [TCAs] preparations available, 840t
SNRIs and tricyclic antidepressants, Antidiabetic agents, oral, 757–759, sulfonamides, 834–836, 840t
547 768t–769t. See also specific agents trimethoprim and trimethoprim-
SSRIs, 546–547 α-glucosidase inhibitors, 761, 768t sulfamethoxazole mixtures,
tetracyclic and unicyclic agents, bromocriptine, 764, 769t 836–837, 840t
547 colesevelam hydrochloride, 764, 769t Antifungal agents, 853–861, 861t, 862t.
clinical indications in drugs lowering glucose by tissue actions, See also specific types
anxiety disorders, 544 759–761 Antifungal agents, dermatologic
depression, 543–544 biguanides, 759–760, 768t oral
eating disorders, 545 thiazolidinediones, 760–761, 768t azole derivatives, 1073
other uses, 545 glucose absorption agents, 761 griseofulvin, 1074
pain disorders, 544 incretin mimics and action prolongers terbinafine, 1074
premenstrual dysphoric disorder, dipeptidyl peptidase-4 inhibitors, topical
544 762–763, 769t allylamines, 1073
smoking cessation, 544 glucagon-like peptide-1 and, 762 azole derivatives, 1073
dosing of, 546, 546t glucagon-like peptide-1 receptor butenafine, 1073
drug interactions in agonists, 762, 769t ciclopirox olamine, 1072
5-HT receptor modulators, pramlintide, 764, 769t nystatin and amphotericin B, 1073
548–549 sodium-glucose co-transporter 2 tolnaftate, 1073
MAO inhibitors, 549 (SGLT2) inhibitors, 763–764, Antifungal agents, OTC preparations
SNRIs and tricyclic antidepressants, 769t topical, 1124t
548 sulfonylurea receptor binders, 757–759 vaginal, 1124t